Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

190 questions in 24 reviews · Epilepsy

current versions
No studies 190 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intermittent oral ibuprofen vs placebo
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 12 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 18 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral clobazam vs placebo
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 6 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 18 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous zinc sulfate for 6 months vs placebo
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diclofenac vs placebo, followed by oral ibuprofen, paracetamol, or placebo after 8 hours,
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diclofenac vs placebo, followed by oral ibuprofen, paracetamol, or placebo after 8 hours,
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diclofenac vs placebo, followed by oral ibuprofen, paracetamol, or placebo after 8 hours,
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous phenobarbital vs intermittent rectal or oral diazepam
Recurrent seizure at 6 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous phenobarbital vs intermittent rectal or oral diazepam
Recurrent seizure at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous phenobarbital vs intermittent rectal or oral diazepam
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous phenobarbital vs intermittent rectal or oral diazepam
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Continuous phenobarbital vs intermittent rectal or oral diazepam
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diazepam vs intermittent rectal valproate
Recurrent seizure at 18 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diazepam vs intermittent rectal valproate
Recurrent seizure at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diazepam vs intermittent rectal valproate
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diazepam vs intermittent rectal valproate
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent rectal diazepam vs intermittent rectal valproate
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 6 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 18 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral diazepam vs intermittent oral clobazam
Recurrent seizure at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 12 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 18 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 24 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 36 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 48 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral melatonin vs intermittent oral diazepam
Recurrent seizures at 60 months or greater · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Intermittent oral levetiracetam vs placebo (any antipyretics)
Recurrent seizures at 6 months · children with febrile seizures
Prophylactic drug management for febrile seizures in children (2021) · Cochrane
no estimate extractedNRNo studies
Ethosuximide vs lamotrigine
80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Ethosuximide vs lamotrigine
50% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Ethosuximide vs lamotrigine
Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Ethosuximide vs valproate
Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Lamotrigine vs valproate
80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Lamotrigine vs valproate
50% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane
no estimate extractedNRNo studies
Cannabidiol (10 mg/kg and 20 mg/kg) plus ASMs vs placebo plus ASMs
Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age
Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane
no estimate extractedNRNo studies
Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs
Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age
Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane
no estimate extractedNRNo studies
Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs
Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age
Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane
no estimate extractedNRNo studies
Felbamate plus ASMs vs placebo plus ASMs
Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age
Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane
no estimate extractedNRNo studies
Felbamate plus ASMs vs placebo plus ASMs
Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age
Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane
no estimate extractedNRNo studies